Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.15 USD | -1.43% | -6.60% | +2.96% |
28/06 | US urges dismissal of lawsuit seeking menthol cigarette ban | RE |
24/06 | European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 7.77 and 7.25 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an enterprise value anticipated at 3.28 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.96% | 68.62B | - | ||
+7.62% | 157B | B- | ||
+12.26% | 21.73B | A- | ||
+37.85% | 7.44B | B- | ||
+102.00% | 2.65B | - | C+ | |
-1.41% | 1.8B | - | ||
-3.01% | 1.72B | - | D+ | |
-29.23% | 1.17B | - | B+ | |
0.00% | 646M | - | - | |
+23.21% | 571M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- BTAFF Stock
- Ratings British American Tobacco p.l.c.